Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Cool!

<< Previous

Bullboard Posts

Next >>

Comment by gordo323on Jun 06, 2023 10:19am

238 Views

Post# 35482264

RE:Cool!

Lesalpes29 wrote: Dr. Lbiati is an internationally trained medical doctor, who utilizes her extensive clinical and business background to assist biopharmaceutical organizations to achieve their strategic objectives through: systematic achievement of their value inflection milestones, partnering of their promising drug candidates with large international pharmaceutical companies and ultimately increasing shareholder value.

An other indication that we are close to something good! GL

INTERNATIONAL POLICY DIGEST

KAOUTHAR LBIATI

KAOUTHAR.LBIATI@GMAIL.COM

Dr. Kaouthar Lbiati is a Medical Doctor (MD) with a Master’s of Science in International Policy and Health Economics from the London School of Economics (LSE), Health Policy Specialist at the Moroccan Institute of Strategic Intelligence (IMIS), and is Vice President of Corporate and Product Strategy of CYTOVIA Therapeutics.